PCSA
Processa Pharmaceuticals, Inc.
There isn't enough reported data to score PCSA yet.
PCSA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
PCSA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
PCSA PE Valuation
PCSA has no meaningful PE right now: it lost money over the past year.
PCSA Forward outlook
There aren't enough analyst estimates for PCSA to show an outlook.
PCSA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$585.00 | -$30.00 |
| Q2 2023 | -$730.00 | -$265.00 |
| Q1 2023 | -$840.00 | -$435.00 |
| Q4 2022 | -$850.00 | -$475.00 |
| Q3 2022 | -$555.00 | +$560.00 |
| Q2 2022 | -$465.00 | +$830.00 |
| Q1 2022 | -$405.00 | +$855.00 |
| Q4 2021 | -$375.00 | +$895.00 |
PCSA is still losing money, but far less than before: $33.50 per share over the past year, against $1,295.00 at its worst in mid-2021.
PCSA Quarterly Revenue
PCSA's revenue is shrinking: $0 last quarter.
PCSA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2M | +$274.5K |
| Q1 2026 | -$3.6M | -$860.8K |
| Q4 2025 | -$2.9M | -$652.9K |
| Q2 2025 | -$2.3M | +$1.1M |
| Q1 2025 | -$2.7M | -$681K |
| Q4 2024 | -$2.2M | -$123.9K |
| Q2 2024 | -$3.3M | -$1.3M |
| Q1 2024 | -$2M | +$65.2K |
PCSA has burned cash in almost every quarter: −$12M over the past year, against −$11M the year before.
PCSA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.9% | +128K shares |
| 1 year | +622% | +2.4M shares |
| 3 years | +8528% | +2.7M shares |
| 5 years | +24836% | +2.7M shares |
PCSA has 3M diluted shares, up 622% from a year ago.
PCSA Net Leverage
PCSA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PCSA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 45.9 | Neutral |
PCSA's weekly RSI is 42 (neutral) and its Stochastic is 46 (neutral).
PCSA PE vs Healthcare Sector
PCSA has no meaningful PE right now: it lost money over the past year.
PCSA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.77 | 4% above |
| 20 week MA | $2.04 | 9.8% below |
| 50 week MA | $2.63 | 30% below |
| 100 week MA | $5.96 | 69% below |
| 200 week MA | $80.7 | 98% below |
PCSA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 98% below its 200-week average.
PCSA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,375.0 | $3,700.0 | -42% |
| 2021 | $3,700.0 | $2,565.0 | -31% |
| 2022 | $2,565.0 | $605.0 | -76% |
| 2023 | $605.0 | $167.3 | -72% |
| 2024 | $167.3 | $22.8 | -86% |
| 2025 | $22.8 | $3.92 | -83% |
| 2026 YTD | $3.92 | $1.84 | -53% |
PCSA has finished every year since 2020 lower, and it's down 53% so far in 2026.